Stay updated with breaking news from Evidence Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On January 11, 2022, the Centers for Medicare and Medicaid Services (“CMS”) published an anticipated proposed National Coverage Determination (“NCD”) decision memorandum that begins the...
Reston, VA – Yesterday, the Centers for Medicare and Medicaid Services (CMS) announced that it proposes to cover FDA-approved monoclonal antibodies
Medicare took a highly unusual step to restrict access to the controversial, pricey Alzheimer’s drug Aduhelm.
On November 12, 2021, the Centers for Medicare and Medicaid Services (CMS) issued a final rule rescinding the Medicare Coverage of Innovative Technology and Definition of "Reasonable and Necessary"...
Using clear terminology helps all parties manage the conditions for new drugs coming to market